Norgine signs deal to co-market Moviprep in Eastern Europe with PharmaSwiss SA
UK-based specialty drugmaker Norgine has signed a deal to co-market Moviprep (NRL994), its product for bowel cleansing before colonoscopy, in eastern Europe with PharmaSwiss SA. Financial details of the accord were not disclosed. PharmaSwiss is a medium-sized pharmaceutical company that specializes in forming exclusive, long-term partnerships to help drugmakers penetrate the smaller central and eastern Europe markets. Norgine currently markets Moviprep in Europe and licensed the US rights to the agent in 2005 to local firm Salix Pharmaceuticals.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze